Einstein/Montefiore Department of Medicine

Dr. Jill Crandall Named Chief, Division of Endocrinology

Jill P. Crandall, MD, has been named Chief, Division of Endocrinology. 

Dr. Jill CrandallDr. Crandall, professor of Medicine (Endocrinology) and Jacob A. and Jeanne E. Barkey Chair in Medicine, was appointed interim division chief of Endocrinology in November 2017, upon Dr. Norman Fleischer’s retirement.  As interim chief, Dr. Crandall began reorganizing clinical operations and worked with the Department of Medicine to create a plan for expanded in-patient diabetes management service.
Going forward, Dr. Crandall will aim to expand and enhance the Division of Endocrinology’s clinical programs in diabetes and obesity. This will include recruiting new faculty; managing the move into the newly-formed Diabetes and Metabolism Institute, still in the planning stage, which will be named for Dr. Fleischer; and creating an obesity treatment and research center to help tackle the growing obesity epidemic in the Bronx and beyond. Dr. Crandall will also recruit additional research faculty to augment our existing research portfolio, especially in the area of obesity, emphasizing clinical and translational research; and she will strengthen our endocrinology fellowship program by expanding the fellowship and providing more comprehensive training in diabetes and obesity.

Dr. Crandall’s impressive skills and accomplishments make her an excellent choice to serve as division chief. Recruited in 2001 to Montefiore-Einstein from Mount Sinai, Dr. Crandall is an internationally renowned expert in diabetes and metabolism with $1.8 million in NIH funding. She is a principal investigator and national leader in the NIH-funded Diabetes Prevention Program Outcomes Study. The research showed that sustaining weight loss or taking an anti-diabetic drug can stave off type-2 diabetes in people at high risk for the disease. 

Dr. Crandall is also a PI for GRADE, a national multisite comparative effectiveness study of glucose-lowering medications for type 2 diabetes; and PERL, a clinical trial for preventing progression of diabetic nephropathy. Dr. Crandall also has received funding from the American Diabetes Association to study the red wine ingredient resveratrol in the prevention of diabetes and has served as PI for several other NIH-sponsored trials in diabetes and endocrinology.
A highly skilled and effective leader, Dr. Crandall also serves as director of the Translational Research Core (TRC) of the Diabetes Research Center, which provides technical support and expertise for investigators who conduct diabetes-related clinical research.  As an attending physician at the Montefiore Diabetes Clinic, Dr. Crandall maintains an active consultative practice in endocrinology.

Contact Us

Department of Medicine
Albert Einstein College of Medicine
Jack and Pearl Resnick Campus
Belfer Building - Room 1008
1300 Morris Park Avenue
Bronx, NY 10461 (directions)

Physicians and Patients:
866-MED-TALK (866-633-8255)

Internal Medicine Residency Program:

Administrative Questions:
Fax: 718-430-8659

Click here to log in